The following is a summary of "Exploring the impact of metabolic comorbidities on epicardial adipose tissue in heart failure ...
BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) has become the most prevalent type of heart failure, but ...
The HFpEF Summit is a biannual, two-day meeting bringing together internationally recognized leaders in the clinical, biological, and translational study of HFpEF. This summit focused on the latest ...
A team of scientists led by Northwestern Medicine investigators have uncovered new details about a deadly heart condition ...
EchoGo® Heart Failure remains the first and only AI platform capable of identifying HFpEF from a routine echocardiogram. The ...
The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with ...
New data show the machine learning algorithms may be used to detect PCWP elevation, aiding in assessment of heart failure with preserved ejection ...
Tirzepatide offers a promising treatment for patients with obesity, chronic kidney disease, and heart failure, improving both ...
Heart failure with preserved ejection fraction (HFpEF) accounts for nearly half of all heart failure cases, but has limited disease-modifying therapeutics. SRD-002 is a gene therapy utilizing an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback